The impact of genomics on anti-infectives drug discovery and development (Q34960308)

5 August 2017

1 reference

title

The impact of genomics on anti-infectives drug discovery and development (English)

1 reference

5 August 2017

1 reference

1 reference

Tanya Parkinson

1

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

Trends in Microbiology

1 reference

5 August 2017

10

1 reference

5 August 2017

10 Suppl

1 reference

5 August 2017

S22-6

1 reference

In vivo genetic analysis of bacterial virulence

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Use of signature-tagged mutagenesis in pathogenesis studies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

IVET and RIVET: use of gene fusions to identify bacterial virulence factors specifically induced in host tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Comparing genomes within the species Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Virogenomics: a novel approach to antiviral drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Functional discovery via a compendium of expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Computer-aided target selection-prioritizing targets for antifungal drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Estimating the number of protein folds and families from complete genome data

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Structural genomics: A pipeline for providing structures for the biologist

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Antibacterial vaccine design using genomics and proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

The pharmacogenomics of HIV therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Privacy and confidentiality of genetic information: what rules for the new science?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Ethical considerations in clinical pharmacogenomics research

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

Ethical and legal implications of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

The genomics and genetics of human infectious disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2802%2902427-7

7 January 2021

10.1016/S0966-842X(02)02427-7

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12377564